Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Gilead
FOLLOW
Gilead, Latest News
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs.
Read More
National :
Wardha-based Genetek Lifesciences to manufacture Remdesivir drug amid severe shortage
Genetek Lifesciences, Maharashtra's Wardha-based company, has been given permission to manufacture 30,000 vials of COVID-19 drug Remdesivir injections per day. ...
National :
Wardha-based Genetek Lifesciences to matufacture Remdesivir drug amid severe shortage
Genetek Lifesciences, Maharashtra's Wardha-based company, has been given permission to manufacture 30,000 vials of COVID-19 drug Remdesivir injections per day. ...
National :
Centre prohibits exports of Remdesivir till COVID-19 situation in India improves
The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves. ...
National :
Fresh guidelines for Remdesivir injection for private hospitals treating govt patients in Karnataka
The Karnataka government has said that while Remdesivir injections have already been used in government hospitals, the same benefits will be extended to the patients referred through the government to private hospitals. ...
Health :
EU signs deal on Remdesivir supply for COVID-19 treatment
Brussels, July 30 The European Commission said that it has signed a 63 million-euro contract with American pharmaceutical ... ...
Business :
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial. ...
National :
India to soon begin domestic production of Remdesivir drug to fight COVID-19
India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for "restricted emergency use" on COVID-19 patients. ...
National :
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on hospitalised patients
In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergenc ...
Previous Page
Next Page